Literature DB >> 33514672

Young people's perspectives on patient-reported outcome measures in inflammatory arthritis: results of a multicentre European qualitative study from a EULAR task force.

Erika Mosor1, Paul Studenic2,3, Alessia Alunno4, Ivan Padjen5,6, Wendy Olsder7,8, Sofia Ramiro9,10, Ilaria Bini7,11, Nele Caeyers12,13, Laure Gossec14,15, Marios Kouloumas16, Elena Nikiphorou17,18, Simon Stones19,20, Tanita-Christina Wilhelmer7,21, Tanja A Stamm22.   

Abstract

INTRODUCTION: Although patient-reported outcome measures (PROMs) are increasingly used in clinical practice and research, it is unclear whether these instruments cover the perspective of young people with inflammatory arthritis (IA). The aims of this study were to explore whether PROMs commonly used in IA adequately cover the perspective of young people from different European countries.
METHODS: A multinational qualitative study was conducted in Austria, Croatia, Italy and the Netherlands. Young people with either rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), Still's disease, psoriatic arthritis (PsA) or spondyloarthritis (SpA), aged 18-35 years, participated in semistructured focus group interviews. Thematic analysis was used and data saturation was defined as no new emergent concepts in at least three subsequent focus groups.
RESULTS: Fifty-three patients (21 with RA/JIA/Still's, 17 with PsA, 15 with SpA; 72% women) participated in 12 focus groups. Participants expressed a general positive attitude towards PROMs and emphasised their importance in clinical practice. In addition, 48 lower level concepts were extracted and summarised into 6 higher level concepts describing potential issues for improvement. These included: need for lay-term information regarding the purpose of using PROMs; updates of certain outdated items and using digital technology for data acquisition. Some participants admitted their tendency to rate pain, fatigue or disease activity differently from what they actually felt for various reasons.
CONCLUSIONS: Despite their general positive attitude, young people with IA suggested areas for PROM development to ensure that important concepts are included, making PROMs relevant over the entire course of a chronic disease. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  arthritis; patient-reported outcome measures; qualitative research

Year:  2021        PMID: 33514672      PMCID: PMC7849893          DOI: 10.1136/rmdopen-2020-001517

Source DB:  PubMed          Journal:  RMD Open        ISSN: 2056-5933


Patient-reported outcome measures (PROMs) have been used for different purposes in routine clinical practice, research and health services management in recent decades, particularly in the field of chronic diseases. This is the first study that explores perspectives and views of young people with inflammatory arthritis (IA) on widely used PROMs. Young people in all countries and disease areas did not feel sufficiently informed about the value of PROMs and the reasons for collecting patient-reported outcomes in addition to clinical outcomes. From the perspective of young people, commonly used functional assessments seem to be outdated and overlook current relevant issues. These include career planning, caring for others such as children, losing friends, participating in social life (like going out in the evening), being excluded from physical activities at school and university, and using technological devices including smartphones and computers. Young people considered a large number of functional items too ‘easy’, for example, walking and eating, while other more complex activities in daily life, such as using public transport or preparing meals were missing at all. The results of our study will change the use of PROMs in young people with IA in clinical practice and research. In the future, young people with IA should be involved in the adaptation of existing PROMs and the development of new instruments to ensure that important concepts are included, making PROMs relevant over the entire course of a chronic disease.

Introduction

Patient-reported outcomes (PROs) constitute an essential part of health outcomes.1 On an individual level, the measurement of PROs is a crucial component of patient-centred care, building the basis for shared decision-making, patient empowerment, engagement and self-management.2 When used in routine clinical practice, PROs can positively influence the relationship between patients and their healthcare providers.3 4 PROs allow a structured assessment of the type and severity of symptoms that patients experience, as well as the impact of their disease and subsequent treatment on their life. Furthermore, aggregated PRO data can also be used to drive healthcare quality improvement initiatives on an institutional level; and for population health monitoring and reimbursement decision-making on a macro-level.2 Several outcome domains can only be measured in a self-reported manner. Examples are pain, fatigue, functioning in real-life situations and health-related quality of life.2 5 To accurately quantify patients’ experiences, patient-reported outcome measures (PROMs) are used. PROMs are defined as assessments of subjective health outcomes, based on responses provided directly by patients themselves without subsequent interpretation or alteration of the responses by health professionals (HPs) or anyone else.6 In the development and the selection of suitable PROMs, various methodological issues and measurement properties must be considered. These include the reliability, validity, responsiveness and interpretability of the respective instruments.7 8 PROMs have been increasingly applied in routine clinical practice and research in recent decades, particularly in the field of chronic diseases.9 10 In their work on PROs in rheumatoid arthritis (RA), van Tuyl and Michaud11 provided key examples of valid and reliable, commonly used PROMs in rheumatology. However, in order to address the impact of chronic diseases over their entire course, PROMs should be equally applicable and valid across a patient’s lifespan. Otherwise, adaptations for certain age groups may be required.3 In addition to the validity, reliability, responsiveness and acceptability of the measurements, PROMs need to cover what matters to patients.12 While a few studies have been conducted in rheumatology to explore whether PROMs cover the issues important to patients with different chronic autoimmune diseases, none of them focused specifically on young people.13–15 Inflammatory arthritis (IA) affects people of all age groups and PROMs play an important role to determine if a treatment is successful or not. However, to date, it has not been investigated whether PROMs commonly used in IA adequately include the perspectives of young people. This need was recognised by the EULAR and an international task force on incorporating the perspective of young people with IA into outcomes assessment was established. A qualitative approach was adopted to explore the perspectives of young people with IA on the content and practical use of the most commonly used PROMs in a broader European context. On this basis, the aims of our study were to explore whether commonly used PROMs in IA adequately cover the perspective of young people with IA from different European countries.

Methods

Study design and participants

A multinational qualitative study was conducted in Austria (AT), Croatia (HR), Italy (IT) and the Netherlands (NL). Young people with IA aged between 18 and 35 years, treated in rheumatology centres, with a disease duration of at least 1 year, and a formal diagnosis of one of three IA disease areas: (1) RA, juvenile idiopathic arthritis (JIA) and Still’s disease; (2) spondyloarthritis (SpA); (3) psoriatic arthritis (PsA), were included in the present study. All participants were contacted by telephone either by local investigators or patient organisations and appointments for participation in focus groups at the local centres or the location of the patient association (in the Netherlands) were made. Qualitative research typically uses small sample sizes with a diverse range of participants to explore the personal experiences and views of people on a specific topic. Based on earlier studies,12 15 16 disease-specific focus groups were conducted in each country. Data saturation was defined as no new emergent concepts in at least three subsequent focus groups.17 18 In order to determine the number of emergent concepts in each focus group session, data analysis commenced when first transcripts were available and proceeded in parallel to data collection.19

Data collection

HPs and patient research partners (PRPs) co-developed, piloted and finalised the semistructured interview guide.21 It included questions on the perspectives and views of the participants on currently used PROMs which were selected based on a literature review and an online voting process. From 16 PROMs for RA, 19 PROMs for PsA and 15 PROMs for SpA, which were identified in the literature review, the study team in each country ranked the top five most commonly used PROMs based on their own experience. Subsequently, an agreement was made regarding five often used PROMs for each of the disease areas to be provided to the focus group members in printed form as a basis for discussion (table 1). The focus group moderator introduced these PROMs as examples. The interview questions are depicted in online supplemental table 1.
Table 1

PROMs selected for discussion in the focus groups

Name of instrument and referenceMain conceptUse in FGs
The Health Assessment Questionnaire27FunctioningRA/JIA/Still’s disease, PsA
Bath Ankylosing Spondylitis Functional Index28FunctioningSpA
Single item scale for assessing pain43shown as Visual Analogue Scale and Numeric Rating Scale 0–10PainAll FGs
Single item scale for assessing disease activity—Patient Global Assessment33 two differently phrased questions were shown‘Considering all the ways in which your arthritis may affect you at this time, please make a mark below to show how you are doing’, and ‘How would you rate your disease activity today?’Disease activityAll FGs
Functional Assessment of Chronic Illness Therapy-Fatigue44FatigueAll FGs
The 36-Item Short Form Health Survey45General healthAll FGs

FGs, focus groups; JIA, juvenile idiopathic arthritis; PROMs, patient-reported outcome measures; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, spondyloarthritis.

PROMs selected for discussion in the focus groups FGs, focus groups; JIA, juvenile idiopathic arthritis; PROMs, patient-reported outcome measures; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, spondyloarthritis. A focus group facilitation guide, including transcription instructions, was provided to support local centres while ensuring data collection was harmonised. The interviews were conducted by trained local investigators with experience in qualitative research data acquisition between March and August 2018, audio-recorded, transcribed verbatim and translated into English. Data coding and initial analyses were primarily undertaken by the first author (EM). During a face-to-face meeting of the EULAR task force members, the concepts were rephrased and organised into a scheme of higher and lower level concepts, with input from the local investigators, PRPs and HPs.

Data analysis

Descriptive statistics were used to summarise the characteristics of participants.22 Thematic analysis of qualitative data followed a modified form of ‘meaning condensation’,23 facilitated by using ATLAS.ti software24 to manage and organise the data. Thematic analysis comprised the following steps (figure 1): all transcripts were screened and read. Queries concerning content were sent to the country teams. Transcripts were then divided into meaning units (defined as specific parts of text, either a few words or a few sentences with a common meaning). Subsequently, initial codes were assigned to the meaning units. Codes could refer to the main topic of a meaning unit, but one meaning unit could also contain more than one code. Associated codes were then grouped into lower level concepts. In a final step, the lower level concepts were summarised into higher level concepts.
Figure 1

Example outlining the different steps of the analysis from a meaning unit to lower and higher level concepts. PROMs, patient-reported outcome measures.

Example outlining the different steps of the analysis from a meaning unit to lower and higher level concepts. PROMs, patient-reported outcome measures.

Rigour and accuracy of the analysis

Several strategies were used to enhance the trustworthiness of the qualitative data.25 Debriefing notes were recorded after each focus group interview. All local investigators who conducted focus groups checked the transcripts against the audio-recordings for accuracy. After analysing all focus group interviews, the results were discussed with researchers of all centres and reviewed by other task force members (PRPs and HPs who were not involved in the analysis of the transcripts). Finally, the consolidated criteria for reporting qualitative research Checklist26 was used to ensure the high quality of reporting the study results (online supplemental table 2).

Patient and public involvement

PRPs (WO, IB, NC, MK, SS and T-CW) were part of the task force and included in all stages of the study. Furthermore, they will disseminate the results in lay language after publication.

Results

Participant characteristics

Saturation was reached after conducting 12 focus groups (online supplemental table 3), including 53 young people with a mean age±SD of 28±5 years (11 people with RA, 8 with JIA, 2 with Still’s disease, 15 with SpA and 17 with PsA; see table 2). In total, 18 hours and 22 min of discussion were recorded, resulting in 269 pages of transcript.
Table 2

Characteristics of participants

Disease areaRA/JIA/Still’s diseaseSpAPsAAll
N21151753
Women, n (%)17 (81.0)7 (46.7)14 (82.4)38 (71.7)
Age (±SD) participants*Range of age in years28 (±4)19–3428 (±5)21–3528 (±5)20–3528 (±5)19–35
Disease duration in years (±SD)*Range of disease duration in years11 (±9)1–286 (±5)1–185 (±4)1–158 (±7)1–28
Multimorbidity, n (%)6 (28.6)9 (60.0)7 (50.0)22 (41.5)
Current medication, n (%)
 cDMARDs14 (66.7)3 (20.0)7 (41.2)24 (45.3)
 bDMARDs14 (66.7)6 (40.0)7 (41.2)27 (50.9)
 tsDMARDs001 (5.9)1 (1.9)
 Corticosteroids9 (42.9)1 (6.7)1 (5.9)11 (20.8)
 NSAIDs8 (38.1)7 (46.7)5 (29.4)20 (37.7)
Educational level, n (%)
 Lower and/or upper secondary education (ISCED levels 2 and 3)4 (19.0)4 (26.7)4 (23.5)12 (22.6)
 Post-secondary non-tertiary education and short-cycle tertiary education (ISCED levels 4 and 5)3 (14.3)3 (20.0)4 (23.5)10 (18.9)
 Bachelor’s, Master’s, Doctoral or equivalent levels (ISCED levels 6, 7, 8)14 (66.7)8 (53.3)9 (52.9)31 (58.5)
Employment status, n (%)
 Full-time (30 hours or more) per week9 (42.9)8 (53.3)7 (41.2)24 (45.3)
 Part-time up to 30 hours per week3 (14.3)3 (20.0)4 (23.5)10 (18.9)
 Education/internship/student5 (23.8)4 (26.7)5 (29.4)14 (26.4)
 Unemployed4 (19.0)1 (6.7)1 (5.9)6 (11.3)
 Maternity leave/sabbatical001 (5.9)1 (1.9)
Self-reported activity level compared with other people of the same age, n (%)
 Physically more active4 (19.0)4 (26.7)3 (17.6)11 (20.8)
 About as active7 (33.3)5 (33.3)10 (58.8)22 (41.5)
 Less active10 (47.6)6 (40.0)4 (23.5)20 (37.7)

N total number of participants.

n (%) number of participants (percentage).

*Age (±SD), mean age (SD).

bDMARDs, biological disease-modifying anti-rheumatic drugs; cDMARDs, conventional disease-modifying anti-rheumatic drugs; ISCED, International Standard Classification of Education; JIA, juvenile idiopathic arthritis; NSAIDs, non-steroidal anti-inflammatory drugs; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, spondyloarthritis; tsDMARDs, targeted synthetic disease-modifying anti-rheumatic drugs.

Characteristics of participants N total number of participants. n (%) number of participants (percentage). *Age (±SD), mean age (SD). bDMARDs, biological disease-modifying anti-rheumatic drugs; cDMARDs, conventional disease-modifying anti-rheumatic drugs; ISCED, International Standard Classification of Education; JIA, juvenile idiopathic arthritis; NSAIDs, non-steroidal anti-inflammatory drugs; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, spondyloarthritis; tsDMARDs, targeted synthetic disease-modifying anti-rheumatic drugs.

A general positive attitude towards PROMs

All participants expressed a general positive attitude towards PROMs and acknowledged their importance in clinical practice. Participants of all focus groups across all diseases described that PROMs had made a meaningful difference in their treatment, in that HPs addressed important issues which impacted on daily life, based on PROMs. Furthermore, PROMs were perceived as useful regarding self-management. One participant described this in the following way: There are always questions like, ‘How have you been since the last check-up, have there been any changes’. And I like that each time when I am filling out those questionnaires. It is great, because I can be monitored in relation to the previous time. (Female, 22, SpA, Croatia)

Suggestions for adapting PROMs to young people

Forty-eight lower level concepts pertaining to suggested improvement of PROMs from the perspective of young people with IA were organised into six higher level concepts (table 3).
Table 3

Six higher level and 48 lower level concepts of suggested adaptions of PROMs according to young people with IA

Higher level conceptsLower level conceptsQuotes from interview transcripts
 Information, transparency and clarity regarding the purpose of PROMs are often missing

Reasons for using PROMs are often not known

Need for definition/explanation of terms

Uncertainty what to tick

Questions are incorrectly or not answered

Questions incite anxiety and/or fear

Feedback on PROM results is appreciated

Information about PROM results is available for members of the healthcare team

Well, I always wonder what exactly happens with those questionnaires. The doctor does not talk about it. He just transfers it to the computer. I don’t know what happens with it later on. It disappears in the cupboard and nobody looks at it anymore. (Female, 25, SpA, the Netherlands)You are expecting that… a patient for himself… defines what [disease] activity is. No, you must direct a patient, you must ask pointed questions, what exactly you want me to answer. (Female, 30, RA, Croatia)I had to answer, ‘Can you cut the meat with the knife?’ and, ‘Can you walk on flat ground?’. These questions really scared me. Can the situation worsen? Will there be a time in which I cannot do those things anymore? When answering these questionnaires, you are alone. Such kind of questionnaire should be explained to a sick person and filled out together with the doctor. (Female, 27, PsA, Italy)I always think my rheumatologist and my nurse are looking at two different worlds of my disease and they never really talk about it, that’s how it feels. (Female, 21, SpA, the Netherlands)
 PROMs on daily functioning were seen as outdated

PROMs are not up to date

Inappropriate questions for young people

Items relevant to young people need to be added

Questions (wording) need to be reformulated

PROMs should be developed for different age groups

I am feeling like an old woman, whenever I read it. It is definitely not developed for younger people. (Female, 27, JIA, Austria)I think ‘working on your computer' or ‘typing’ or something could be included. I mean how often do we still use a pen and pencil all day long? It should be a little more up to date. (Female, 25, PsA, the Netherlands)Here it says ‘eat’ but before eating … it is to make lunch, dinner and the meal in general. (Female, 34, Still’s disease, Italy)
 Relevant issues are often not sufficiently addressed when assessing PROs in young people

Future plans for life

Education

Work and career goals

Intimate relationships

Sexuality

Body image and appearance

Family planning

Self-management

Use and outcomes of non-pharmacological treatments

Use of technological/assistive devices

Diet and food intake

Psychosocial aspects of being chronically ill

Social life, including hobbies and sports

Mobility—commuting on public transport and driving

Changing/holding a certain position

Nowadays there is a lot of emphasis on stress, also within our age group, but they never ask whether I worry about the future, family or about starting a family or that sort of things. That is never asked about. But I am much more concerned about what my life will look like than whether I have pain or not. (Female, 27, JIA, the Netherlands)I had never noticed questions about mental state, social life, about the sexual life. All things that actually belong to a healthy active life. Not addressed at all. (Female, 32, SpA, Austria)My appearance has never been brought up for discussion, but it impacts my teaching, my sex life,(…). (Male, 30, PsA, Austria)Some people really experience barriers to start talking about certain topics. It’s nice if you are supported and it is kind of an ice breaker and you're kind of being pulled out of your bubble and it makes it possible for you to talk about it. (Female, 21, JIA, the Netherlands)It is important whether you have pain somewhere and what the doctor can do about it. But I think it is also important what you [as an individual] need. Not only the physical part, but also the mental part, so how are you feeling. I think that is important too. (Male, 22, SpA, the Netherlands)
 The scoring on a rating scale sometimes differs from the current health situation

Scoring differently than the situation was experienced (on purpose to achieve something)

Wish for getting in touch/being recognised

Changes in disease management

To show a flare in between visits (lack of continuous monitoring)

I always score very low, like a 1, 2, or 3, which might look very harmless to the doctor. I often ask myself whether I should score worse, to get recognized. (Male, 30, PsA, Austria)I have the pain for a very long time, perhaps not a ten, but even if it is a 5 it is really unacceptable for me! (Female, 28, PsA, Austria)
 The individual life situation of young people adds essential importance to the results of PROMs

PROMs should not only be used for data gathering, but as a mediator for discussions with HPs

Individualisation of outcome assessment would be appreciated

Using comprehensive PROMs

Using single scales only is insufficient

Clear reference points are often missing (with and without medication, compared with someone without a disease or another patient in remission)

Time frame is not adequate, for example, a longer time frame for scoring pain to include flares

Substantial fluctuation of pain levels is difficult to score

Forgetting the extent of pain over time

Interpreting results is difficult from the patients’ perspective

Losing important information (if PROs are quantified only, qualitative information, for example, in a discussion with the health professional, is missing)

Missing overview about disease course (patients would appreciate an overview regarding their scores over time)

Patients prefer NRS to VAS

Patients were confronted with differently formulated PGA questions

I really miss those questions about my daily life. They never ask me, ‘How do you live your life and how are you doing now?’. (Female, 25, RA, the Netherlands)It needs a number of questions to describe the complexity of the disease. (Male, 30, PsA, Austria)In my opinion it is problematic to estimate disease activity for today. With my medication, or without? At the moment, I am feeling fine, but it won’t be like that without any medication, I guess. And that makes scoring a bit difficult. (Female, 27, PsA, Austria)To me this never makes sense. Never, this scale. I always think that it is much better when you elaborate the matter, on many more pages, with many more sub-questions. (Female, 34, RA, Croatia)It’s always like 'on a scale of this to that, how much pain do you have and how are you doing now?' Well, I don’t know. I already have the disease for ten years, I've just gotten used to the pain, so I do not really know what to fill out. (Female, 25, RA, the Netherlands)I think that if you just take five min to talk to your patient you will reach more than the result of this scale. (Female, 25, SpA, the Netherlands)
 The use of technology for data acquisition was suggested by some young people

New formats for collecting PROs are needed

Continuous monitoring supports self-management

Use of a symptom diary/log could be facilitated by digital technologies

Time-saving for patients and HPs

Nowadays this is done on the tablet. (Female, 27, JIA, the Netherlands)A pain dairy would be great.(…)to get a better over-view about the disease course. (Female, 32, SpA, Austria)Sometimes I do not want to answer with a whole story.(…)but I can also do that questionnaire [HAQ] digitally at my hospital. That is nice! (Female, 25, PsA, the Netherlands)

HAQ, Health Assessment Questionnaire; HPs, healthcare professionals; IA, inflammatory arthritis; JIA, juvenile idiopathic arthritis; NRS, Numeric Rating Scale; PGA, Patient Global Assessment; PROMs, patient-reported outcome measures; PROs, patient-reported outcomes; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, spondyloarthritis; VAS, Visual Analogue Scale.

Six higher level and 48 lower level concepts of suggested adaptions of PROMs according to young people with IA Reasons for using PROMs are often not known Need for definition/explanation of terms Uncertainty what to tick Questions are incorrectly or not answered Questions incite anxiety and/or fear Feedback on PROM results is appreciated Information about PROM results is available for members of the healthcare team PROMs are not up to date Inappropriate questions for young people Items relevant to young people need to be added Questions (wording) need to be reformulated PROMs should be developed for different age groups Future plans for life Education Work and career goals Intimate relationships Sexuality Body image and appearance Family planning Self-management Use and outcomes of non-pharmacological treatments Use of technological/assistive devices Diet and food intake Psychosocial aspects of being chronically ill Social life, including hobbies and sports Mobility—commuting on public transport and driving Changing/holding a certain position Scoring differently than the situation was experienced (on purpose to achieve something) Wish for getting in touch/being recognised Changes in disease management To show a flare in between visits (lack of continuous monitoring) PROMs should not only be used for data gathering, but as a mediator for discussions with HPs Individualisation of outcome assessment would be appreciated Using comprehensive PROMs Using single scales only is insufficient Clear reference points are often missing (with and without medication, compared with someone without a disease or another patient in remission) Time frame is not adequate, for example, a longer time frame for scoring pain to include flares Substantial fluctuation of pain levels is difficult to score Forgetting the extent of pain over time Interpreting results is difficult from the patients’ perspective Losing important information (if PROs are quantified only, qualitative information, for example, in a discussion with the health professional, is missing) Missing overview about disease course (patients would appreciate an overview regarding their scores over time) Patients prefer NRS to VAS Patients were confronted with differently formulated PGA questions New formats for collecting PROs are needed Continuous monitoring supports self-management Use of a symptom diary/log could be facilitated by digital technologies Time-saving for patients and HPs HAQ, Health Assessment Questionnaire; HPs, healthcare professionals; IA, inflammatory arthritis; JIA, juvenile idiopathic arthritis; NRS, Numeric Rating Scale; PGA, Patient Global Assessment; PROMs, patient-reported outcome measures; PROs, patient-reported outcomes; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, spondyloarthritis; VAS, Visual Analogue Scale. Higher level concept one addressed the need for additional information regarding the purpose of using PROMs. Young people in all countries and disease areas did not feel sufficiently informed about the value of PROMs and the reasons for collecting PROs in addition to clinical outcomes. They thought that they were asked to fill in PROMs because it was commonly done, for study reasons only or to keep them busy while waiting at the outpatient clinic. Participants in all 12 focus groups (100%) described uncertainties regarding the terminology used in the PROMs. They suggested simpler wording or clearer definitions, as young people were often confused, ashamed or even scared in case of difficulties to understand and would not ask for clarification. Some participants also pointed out that the value of PROMs seems limited, if the HPs have no time to discuss the PROM results with them and if the results are not available for all members of the healthcare team. Furthermore, some participants mentioned that in order to be suitable to young people, some of the items within PROMs would need to be updated to ensure they are relevant for young people in current times (higher level concept two). In particular, this related to the PROMs which address functioning in daily life. A young man expressed it as follows: I think it’s just an old people’s questionnaires, indeed. Maybe we have kind of an old people’s body, but with this you are really confronted with that. (Male, 22, SpA, the Netherlands) Moreover, young people considered a large number of functional items too ‘easy’, for example, walking, while other issues related to mobility and physical activity, such as participating in physical activities similar to people without chronic diseases of the same age, or sitting in front of a computer for the entire day, are not covered at all. Likewise, eating was considered too easy, while preparing meals was missing. Some participants explained that reference to ‘easy’ items had incited fear, implying that someone might not be able to walk in later stages of IA. Interestingly, participants in one focus group (RA/JIA/Still’s disease, the Netherlands) discussed the need for developing different PROMs for people of different ages. In comparison, all other participants suggested to extend the questionnaires to use the same PROMs for younger and older adults. Issues important to young people should be added and regularly assessed (higher level concept three). These include problems with using technological devices, like smartphones and computers, difficulties with career plans, caring for others (for example, children), loss of friends, social life participation (such as going out in the evening), being excluded from physical activities at school and university, and challenges with regard to sexuality. The fourth higher level concept referred to planned, erroneous reporting from young people. Some participants mentioned that they had purposely rated their pain, fatigue, disease activity or other symptoms differently from what they actually felt. Some of them had rated better, others worse than the situation had been experienced. The reasons behind this were diverse and included intentions to trigger changes in their disease management, often as an attempt to more accurately demonstrate how they had been feeling since their last visit, or even mirrored undisclosed fears. However, these reports may have a severe impact on an individual’s treatment, independent of the reason. A participant described the following example: Well, I answer those questions more positively than how it goes, because I'm afraid they might think I'm depressed or something and send me to a psychiatrist. (Female, 25, SpA, the Netherlands) Higher level concept five focused on individualising PROMs. Participants in the majority of the focus groups expressed that they would like to talk about their personal experience with IA and wished PROMs to be tailored to their individual needs and goals. In addition, length and comprehensiveness of PROMs were included in this higher level concept. Some participants requested that several issues important and meaningful for young people with IA should be adequately addressed in the PROMs and taken up and discussed in the subsequent interactions with interdisciplinary healthcare teams. Some of these participants even questioned the comprehensiveness of PROMs at all, since these tools can never encompass the entire spectrum and the full impact of IA on daily life. This theme was somewhat ambiguous, as other participants criticised the length of some PROMs, contradicting the suggestion of comprehensiveness. Nonetheless, single item scales were seen as insufficient and too narrow in focus, compared with tools which comprehensively assess the impact of a disease in daily life by young people in all countries and disease areas. The sixth higher level concept covered the desire to use digital technology for data acquisition and access to PROM data. Participants were of the opinion that continuous monitoring could support young people in self-managing their health and well-being. Moreover, participants felt that by using technology, HPs would be more able to share the information about PROs with other HPs involved in the care of young people with IA.

Concepts of all disease areas and all countries

Eighteen (38%) of the lower level concepts were mentioned in all three disease areas and four countries (table 4, concepts in bold). Interestingly, the largest overlap was found in uncertainties regarding the terminology used in the PROMs and the need for clearer definitions and explanations. This concept was mentioned in all focus groups (100%). Consequently, these concepts may represent important generic perspectives of young people regarding PROMs.
Table 4

Similarities and differences of concepts addressed on a disease specific and country level

Higher level conceptLower level concept (LLC)LLC per disease groupLLCs per country
648RA/JIA/Still’s diseasePsASpAATHRNLIT
1. Information, transparency and clarity regarding the purpose of PROMs are often missingReasons for using PROMs are often not known+++++++
Need for definition/explanation of terms+++++++
Uncertainty what to tick+++++++
Questions are incorrectly or not answered++++
Questions incite anxiety and/or fear++++
Feedback on PROM results is appreciated+++++++
Information about PROM results is available for members of the healthcare team++++
2. PROMs on daily functioning were seen as outdatedPROMs are not up to date+++++++
Inappropriate questions for young people+++++++
Items relevant to young people need to be added+++++++
Questions (wording) need to be reformulated++++++
PROMs should be developed for different age groups++
3. Relevant issues are often not sufficiently addressed when assessing PROs in young peopleFuture plans for life++++++
Education+++++
Work and career goals+++++
Intimate relationships+++++
Sexuality++++
Body image and appearance+++
Family planning++++
Self-management++++
Use and outcomes of non-pharmacological treatments+++++++
Use of technological/assistive devices++++
Diet and food intake++++
Psychosocial aspects of being chronically ill+++++++
Social life, including hobbies and sports+++++++
Mobility—commuting on public transport and driving+++++
Changing/holding a certain position+++
4. The scoring on a rating scale sometimes differs from the current health situationScoring differently than the situation was experienced (on purpose to achieve something)+++++++
Wish for getting in touch/being recognised++
Changes in disease management+++
To show a flare in between visits (lack of continuous monitoring)+++
5. The individual life situation of young people adds essential importance to the results of PROMsPROMs should not only be used for data gathering, but as a mediator for discussions with HPs+++
Individualisation of outcome assessment would be appreciated+++++++
Using comprehensive PROMs+++++++
Using single scales only is insufficient+++++++
Clear reference points are often missing (with and without medication, compared with someone without a disease or another patient in remission)+++++
Time frame is not adequate, for example, a longer time frame for scoring pain to include flares+++++++
Substantial fluctuation of pain levels is difficult to score++
Forgetting the extent of pain over time+++++++
Interpreting results is difficult from the patients’ perspective++++++
Losing important information (if PROs are quantified only, qualitative information, for example, in a discussion with the health professional, is missing)+++++++
Missing overview about disease course (patient would appreciate an overview regarding their scores over time)++++++
Patients prefer NRS to VAS++++++
Patients were confronted with differently formulated PGA questions+++++++
6. The use of technology for data acquisition was suggested by some young peopleNew formats for collecting PROs are needed++++++
Continuous monitoring supports self-management+++++
Use of a symptom diary/log could be facilitated by digital technologies+++++
Time-saving for patients and HPs++

Concepts in BOLD were mentioned in all diseases and all countries.

+=LLC which had been mentioned.

AT, Austria; HPs, health professionals; HR, Croatia; IT, Italy; JIA, juvenile idiopathic arthritis; NL, the Netherlands; NRS, Numeric Rating Scale; PGA, Patient Global Assessment; PROMs, patient-reported outcome measures; PROs, patient-reported outcomes; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, spondyloarthritis; VAS, Visual Analogue Scale.

Similarities and differences of concepts addressed on a disease specific and country level Concepts in BOLD were mentioned in all diseases and all countries. +=LLC which had been mentioned. AT, Austria; HPs, health professionals; HR, Croatia; IT, Italy; JIA, juvenile idiopathic arthritis; NL, the Netherlands; NRS, Numeric Rating Scale; PGA, Patient Global Assessment; PROMs, patient-reported outcome measures; PROs, patient-reported outcomes; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, spondyloarthritis; VAS, Visual Analogue Scale.

Discussion

To our knowledge, this is the first study investigating the perspective of young people with IA on PROMs in a wider European context. Although the use of PROMs was highly valued by young people, participants across all countries and disease groups expressed that PROMs often fail to sufficiently encompass the daily challenges of young people with IA and are often experienced as ‘too easy’, for example, the Health Assessment Questionnaire27 and the Bath Ankylosing Spondylitis Functional Index.28 These PROMs lack more ‘difficult’ items referring to the instrumental activities of daily living29 which are essential for an independent life, especially at a younger age. In this context, item response theory (IRT) and computerised adaptive testing are used for the development of innovative patient-reported instruments, such as the Patient-Reported Outcomes Measurement Information System.30 In their study, Fries et al could show that physical function scales using a common metric or IRT-based items can result in greater responsiveness and precision across a broader range of functioning.31 Some issues were seen controversially, for example, the length/shortness versus comprehensiveness of PROMs or developing age-appropriate PROMs versus using the same PROMs across the life course. Although not all participants shared the same opinion, they agreed to complete PROMs no matter how long it would take, if they were adequately informed about the purpose of using these questionnaires and rating scales. The wish for more information, transparency and clarity regarding the reasons for using PROMs and their advantages in healthcare and research were also reported in previous studies with people of an older age.32–36 Therefore, simple and clear explanations for the use of PROMs can be seen as prerequisites in clinical practice and research to ensure that patients feel confident and provide accurate information. It is known that chronic diseases influence major life-changing decisions related to social life, education, job, career choice and family planning.37 Participants in our study suggested that topics related to these areas should be discussed on a regular basis at the time of diagnosis and during subsequent follow-up visits with the healthcare team, for which PROMs could also be used. Interestingly, topics like sexuality, intimate relationships, family planning and work were not mentioned in all focus groups, potential reasons being the different cultural backgrounds or the assumption that these topics were not as relevant as others to be raised during consultations. Although it is advisable that private life aspects are increasingly explored among young people with rheumatic and musculoskeletal diseases (RMDs) including IA, sensitivity is required to prevent unnecessary pressure on young people. Discussing the responses of PROMs together with patients, analysing these responses over time, and including them in shared decisions were highly valued by those participants who had experienced these processes before and were also described in the literature by Fautrel et al and Chewning et al.38 39 However, young people in all focus groups sometimes missed this valuable exchange of information due to time restrictions during consultations. Therefore, some participants in our study suggested using new technology to capture patient-reported data to a larger extent, in order to eventually meet this challenge. For example, patients could complete PROMs ahead of their consultation via a smartphone, tablet or computer, so that the results could be viewed and discussed in clinic. Collecting PROs electronically, as well as sharing and discussing them with healthcare providers in a remote way, might be of great importance during times of a pandemic, such as experienced due to COVID-19. Many young people participating in our study also wished to talk about their personal experiences with their disease and expected PROMs to be tailored to their individual needs and goals. One outcome measure that is used both in clinical work and research to assess the effectiveness of treatment based on personally relevant goals is the Goal Attainment Scale.40 41 It is often used to define and evaluate personalised patients’ treatment goals that are meaningful to patients in a standardised way.42 Our study enabled us to gain deep insights into the perspectives of young people with IA by means of a qualitative study using focus group interviews in four European countries. We included on purpose researchers and patients from one country from Western (NL), Central (AT), Southern (IT) and Southeastern (HR) Europe in our study to ensure cultural diversity, but also include countries with different healthcare systems. Interestingly, concepts that were important from the participants’ point of view were the same, independent from the country data collected. Our results might thus be transferable to some other countries as well. However, there might still be differences between different countries, especially outside Europe, as only a limited number of countries were involved in our study. Future studies could include other countries and/or other disease areas using a quantitative survey that builds on our results. To conclude, the results of our study will change the use of PROMs in young people with IA in clinical practice and research. Young people with IA described a substantial potential for improving PROMs. First, optimising the current use of PROMs in their present form; and second, the potential for adapting PROMs so that they meet the current needs of young people. Our study provides the basis for further research in the field of outcomes research, since the assessment of young people’s perspectives should reach beyond the issues covered in PROMs used within rheumatology. Accordingly, young people with IA and other RMD-related conditions should be involved in the development of new PROMs and the potential adaptation of existing PROMs, to ensure that important concepts are included and address the entire course of a chronic disease. In broader terms, our findings may also be relevant to the use of PROMs in the context of other chronic diseases where individual needs, the perception of health and experience of symptoms vary during the course of life.
  37 in total

Review 1.  Qualitative research in health care. Analysing qualitative data.

Authors:  C Pope; S Ziebland; N Mays
Journal:  BMJ       Date:  2000-01-08

2.  FDA guidance on patient reported outcomes.

Authors:  Jane Speight; Shalleen M Barendse
Journal:  BMJ       Date:  2010-06-21

3.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.

Authors:  Allison Tong; Peter Sainsbury; Jonathan Craig
Journal:  Int J Qual Health Care       Date:  2007-09-14       Impact factor: 2.038

Review 4.  Incorporating the patient's perspective in outcomes research.

Authors:  Betty Hsiao; Liana Fraenkel
Journal:  Curr Opin Rheumatol       Date:  2017-03       Impact factor: 5.006

5.  Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity.

Authors:  Paul Studenic; Helga Radner; Josef S Smolen; Daniel Aletaha
Journal:  Arthritis Rheum       Date:  2012-09

6.  Advancing PROMIS's methodology: results of the Third Patient-Reported Outcomes Measurement Information System (PROMIS(®)) Psychometric Summit.

Authors:  Adam C Carle; David Cella; Li Cai; Seung W Choi; Paul K Crane; S McKay Curtis; Jonathan Gruhl; Jin-Shei Lai; Shubhabrata Mukherjee; Steven P Reise; Jeanne A Teresi; David Thissen; Eric J Wu; Ron D Hays
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2011-12       Impact factor: 2.217

7.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

Review 8.  The History of Patient-Reported Outcomes in Rheumatology.

Authors:  Leigh F Callahan
Journal:  Rheum Dis Clin North Am       Date:  2016-03-17       Impact factor: 2.670

9.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

Authors: 
Journal:  JAMA       Date:  2013-11-27       Impact factor: 56.272

10.  Do patient-reported outcome measures cover personal factors important to people with rheumatoid arthritis? A mixed methods design using the International Classification of Functioning, Disability and Health as frame of reference.

Authors:  Mona Dür; Michaela Coenen; Michaela Alexandra Stoffer; Veronika Fialka-Moser; Alexandra Kautzky-Willer; Ingvild Kjeken; Răzvan Gabriel Drăgoi; Malin Mattsson; Carina Boström; Josef Smolen; Tanja Alexandra Stamm
Journal:  Health Qual Life Outcomes       Date:  2015-02-25       Impact factor: 3.186

View more
  4 in total

1.  The Your Rheum story: involvement of young people in rheumatology research.

Authors:  Ecem Esen; Suruthi Gnanenthiran; Laura Lunt; Janet E McDonagh
Journal:  BMC Rheumatol       Date:  2022-07-05

2.  Economic impact of Juvenile Idiopathic Arthritis: a systematic review.

Authors:  Fernando García-Rodríguez; Augusto Gamboa-Alonso; Sol Jiménez-Hernández; Lucero Ochoa-Alderete; Valeria Alejandra Barrientos-Martínez; Neri Alejandro Alvarez-Villalobos; Gabriela Andrea Luna-Ruíz; Ingris Peláez-Ballestas; Ana Victoria Villarreal-Treviño; Manuel Enrique de la O-Cavazos; Nadina Rubio-Pérez
Journal:  Pediatr Rheumatol Online J       Date:  2021-10-09       Impact factor: 3.054

3.  EULAR points to consider for including the perspective of young patients with inflammatory arthritis into patient-reported outcomes measures.

Authors:  Paul Studenic; Tanja A Stamm; Erika Mosor; Ilaria Bini; Nele Caeyers; Laure Gossec; Marios Kouloumas; Elena Nikiphorou; Wendy Olsder; Ivan Padjen; Sofia Ramiro; Simon Stones; Tanita-Christina Wilhelmer; Alessia Alunno
Journal:  RMD Open       Date:  2022-07

4.  The value of the patient global health assessment in polyarticular juvenile idiopathic arthritis: a nested cohort study.

Authors:  Rebecca Trachtman; Rula Issa; Stephanie Pan; Karen M Wilson; Daniel J Lovell; Karen B Onel
Journal:  J Patient Rep Outcomes       Date:  2021-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.